F&O Call: Nandish Shah recommends to long Glenmark Pharma futures

The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.

Markets, stocks, buy, sell, trading, shares, stock market
Nandish Shah Mumbai
1 min read Last Updated : Jan 06 2023 | 8:02 AM IST
Derivative recommendation on Glenmark Pharma

Buy Glenmark Jan Future at Rs 436
Stop Loss: Rs 427
Target: Rs 450 
Lot Size: 1,450
Approx margin required: Rs 1,33,000

Also Read


Rationale:
  • We have seen long build up in the Glenmark Futures during the January series till now, where we have seen 2 per cent addition (Prov) in Open Interest with price rising by 3 per cent.
     
  • Short term trend of the stock is positive as stock price is trading above its 11 and 20 day EMA.
     
  • Primary trend of the stock is positive as stock price is trading above its 100 and 200 day EMA.
     
  • Momentum Oscillators like RSI (11) is placed above 50 on the daily chart, Indicating strength in the current uptrend.
Note: It is advisable to book profit in the strategy when ROI exceeds 20 per cent.

Disclaimer: Nandish Shah is Sr. Derivatives & Technical Research Analyst at HDFC Securities. He doesn't hold any position in the stock. Views are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :F&O StrategiesGlenmark PharmaceuticalsMarket trendsMarket technicalsstock market tradingstocks technical analysistechnical chartsTrading strategiesStock Recommendations

Next Story